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Abstract
Malaria transmission remains high in Sub-Saharan Africa despite large-scale implementa-
tion of malaria control interventions. A comprehensive understanding of the transmissibility
of infections to mosquitoes may guide the design of more effective transmission reducing
strategies. The impact of P. falciparum sexual stage immunity on the infectious reservoir for
malaria has never been studied in natural settings. Repeated measurements were carried
out at start-wet, peak-wet and dry season, and provided data on antibody responses
against gametocyte/gamete antigens Pfs48/45 and Pfs230 as anti-gametocyte immunity.
Data on high and low-density infections and their infectiousness to anopheline mosquitoes
were obtained using quantitative molecular methods and mosquito feeding assays, respec-
tively. An event-driven model for P. falciparum sexual stage immunity was developed and
fit to data using an agent based malaria model infrastructure. We found that Pfs48/45 and
Pfs230 antibody densities increased with increasing concurrent gametocyte densities;
associated with 55–70% reduction in oocyst intensity and achieved up to 44% reduction in
proportions of infected mosquitoes. We showed that P. falciparum sexual stage immunity
significantly reduces transmission of microscopic (p < 0.001) but not submicroscopic (p =
0.937) gametocyte infections to mosquitoes and that incorporating sexual stage immunity
into mathematical models had a considerable impact on the contribution of different age
groups to the infectious reservoir of malaria. Human antibody responses to gametocyte
antigens are likely to be dependent on recent and concurrent high-density gametocyte
exposure and have a pronounced impact on the likelihood of onward transmission of
microscopic gametocyte densities compared to low density infections. Our mathematical
simulations indicate that anti-gametocyte immunity is an important factor for predicting
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and understanding the composition and dynamics of the human infectious reservoir for
malaria.
Author summary
Submicroscopic gametocyte infections are efficiently transmitted from humans to mos-
quitoes in settings with efficient malaria vectors and may pose challenges for malaria
control and elimination efforts. Our understanding of what mechanisms contribute to
submicroscopic gametocytes infectiousness remains limited. Here we assess the impact of
naturally acquired anti-gametocyte antibodies on malaria transmission to mosquitoes and
on the age-dependent composition of the infectious reservoir and seasonal dynamics.
Anti-gametocyte immunity significantly reduces the infectiousness of high gametocyte
density infections, contributes to explain the age-related profiles of the infectious reservoir
in the study area, whilst submicroscopic gametocyte infections that present with lower
anti-Pfs48/45 and anti-Pfs230 antibody responses commonly remain transmissible to
mosquitoes. Our findings indicate that sexual stage immunity needs to be incorporated in
transmission models to better understand transmission dynamics. Furthermore, tools that
boost sexual stage immunity may reduce transmission to mosquitoes and thus aid elimi-
nation strategies.
Introduction
The 2007 call issued by Bill and Melinda Gates for malaria eradication [1] has rapidly gained
momentum. Malaria has plummeted globally and numerous countries continue to make sig-
nificant progress toward elimination [2–5]. Nevertheless, more than a dozen countries in Sub-
Saharan Africa, representing approximately 80% of the remaining global malaria burden, still
need to considerably improve malaria control interventions substantially to reach levels of
transmission that are suitable for elimination strategies [6]. In these countries where climate
[7] and ecological conditions favor the vector’s life cycle, malaria transmission remains high
and is likely compounded by under-resourced health care systems, resilient vector popula-
tions, and, obligatory for ongoing transmission, a reservoir of infectious individuals [8–11].
Although prioritizing vector control, early diagnosis and treatment of symptomatic malaria
currently remain the foundation of malaria control, actual assessment and management of the
human infectious reservoir may accelerate transmission reduction in highly endemic countries
and contribute to sustaining elimination progress where transmission is low [12, 13].
Considerable efforts in diagnostics have been made to improve malaria case management
and elimination strategies. More sensitive molecular methods now detect previously undiag-
nosed low-density infections [14–16] while point-of-care diagnostics such as rapid diagnostic
tests play an important role in case management and may contribute considerably to elimina-
tion strategies once their sensitivity is improved [17]. Parasite detection or quantification form
imperfect proxies for the infectious reservoir of malaria that can currently only be assessed by
mosquito feeding assays [18–20].
P. falciparum sexual stage immunity may restrict parasite development within the mosqui-
to’s midgut [21–25], and may thus affect the composition and dynamics of the infectious
reservoir that is not only dictated by parasite or gametocyte densities [26]. The infectious reser-
voir for malaria negatively associates with age [11, 27, 28], with conflicting evidence on the
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contribution of submicroscopic infections to transmission [11, 29–33]. The impact of sexual
stage immunity on the human infectious reservoir has never been studied and is not incorpo-
rated in mathematical models that play an increasingly important role in campaign strategies
and policy making decisions [17, 34–36].
Naturally acquired sexual stage immunity is predominantly antibody-mediated rather than
cellular [37, 38]. Antibodies against antigens that are shared between gametocytes and gametes
are acquired upon natural gametocyte exposure and, once ingested as part of the mosquito
blood meal, may interact with gamete surface-expressed antigens such as Pfs48/45 and Pfs230
[24, 39–45] and thereby reduce or completely block human-to-mosquito transmission. Func-
tional sexual stage immunity, transmission reducing activity (TRA), can be estimated using an
in vitro standard membrane feeding assay (SMFA) [46] in which a mixture of cultured gameto-
cytes and purified antibodies is fed to mosquitoes. However, the SMFA may only detect the
highest level of TRA in endemic sera, partly due to its high stringency and reliance on unnatu-
rally high gametocyte densities and on no local malaria vector for African settings, Anopheles
stephensi [47]. It was recently shown that functional TRA that affects the transmission from
natural infections may be missed by the SMFA [48]. The SMFA may thus not be as sensitive to
detect natural transmission reducing activity of field serums that were induced against concur-
rent lower or submicroscopic gametocyte densities. In the current study, we use direct mem-
brane feeding (DMFA) measurements that assess the infectiousness of naturally acquired
gametocytes to locally relevant vectors. DMFA experiments were performed during natural
infections in all age groups from the entire range of infectious gametocyte densities and allow
for the first time a direct assessment of the impact of TRA on natural malaria transmission [25,
41, 49, 50].
Despite the unique richness of the present data, which include hundreds of concurrent
measurements of parasite densities, serological markers, and human infectiousness, the under-
lying dynamics between longitudinal sampling points are complicated: seasonality impacts the
timing of new infection events; age-dependent blood-stage immunity modulates the distribu-
tion of oscillating parasite densities; and recent gametocyte exposure drives changes in sexual-
stage antibody concentrations. In order to assist in the interpretation of statistical relationships
observed in these data, we have taken an existing model of infection and immunity dynamics
in Burkina Faso [51] and extended it to include boost and decay of sexual-stage antibodies.
The goal of the present modeling work is not to identify the optimal model structure or param-
eterization for gametocyte density and sexual-stage antibody dynamics; that will require signif-
icantly more temporal resolution in future longitudinal surveys. Rather, the goal throughout
will be to compare which features of the data might follow directly from a set of plausible
assumptions about unobserved dynamics, and to highlight how this should impact their
interpretation.
Methods
Ethics statement
The study received ethical clearance from the Ethical Review Committee of the Ministry of
Health of Burkina Faso (MS/MESSRS/N˚ 2007–035). Study procedures, risks and benefits
were explained to participants and written informed consent obtained from adults and
parents/guardians of children prior to enrolment. Negative and positive control plasma sam-
ples [25] used in the ELISA were anonymized and provided by Sanquin blood bank (Nijme-
gen, the Netherlands) to the Department of Medical Microbiology, Radboud University
Medical Center, Nijmegen, for malaria research purpose and approved by institutional Review
Board for use in the present study.
Sexual stage immunity and transmission of malaria low density infections
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Field activities
The serological and oocyst data were collected through a longitudinal study on the infectious
reservoir [11]. Data are deposited in the Dryad repository: (http://dx.doi.org/10.5061/dryad.
v60jk42) [52].
The study design and procedures for data analysis and modeling are summarized in Fig 1;
clarifying where conventional statistical models were used to present and analyze study data
and where data were incorporated into the EMOD malaria model to simulate their impact on
malaria transmission and the human infectious reservoir for malaria. Study participants of all
ages living in a hyper-endemic and seasonal malaria transmission setting of Burkina Faso were
randomly recruited from four age groups (< 5 years, 5–14 years, 15–30 years and above 30
years of age) in proportions that reflect local demographic proportions (20%, 30%, 25% and
25% respectively). Individuals were invited to participate; and the first to arrive were enrolled
until samples sizes for the different age groups were reached.
Fig 1. Field study design, data analysis and modeling framework. N = number of observations.
https://doi.org/10.1371/journal.ppat.1007034.g001
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To study infectivity to mosquitoes in relation to parasite density, age, season and sexual
stage immunity, participants were invited to donate blood samples. These samples were used
for parasite detection, mosquito feeding assays and assessment of specific anti-gametocyte
antibodies (prevalence and ELISA optical density as proxy for antibody density). These assess-
ments were performed at the start of the wet season, the peak of the wet season and during the
following dry season.
Parasite detection. To improve our understanding of the relationships among human-to-
mosquito transmission, gametocyte density and sexual stage immunity, P. falciparum asexual
parasite and gametocyte densities were microscopically determined from blood slides by
screening 500–2000 white blood cells (WBC) while assuming a standard count of 8000 WBC/
μL of blood suggesting a detection limit of 16 parasites/μL for trophozoites and 4–16 gameto-
cytes/μL for gametocytes. Nucleic acids were extracted from 100 μL aliquots of venous blood
samples using the guanidium isothiocyanate (GuSCN) / silica procedure [53] for the quantifi-
cation of mature gametocytes by Pfs25 mRNA quantitative nucleic acid sequence based ampli-
fication (QT-NASBA) [54] with a detection limit 0.01 gametocyte/μL.
Mosquito feeding experiments. Direct membrane feeding assays (DMFA) were per-
formed to assess human-to-mosquito transmission capability [20]. A venous blood sample was
offered to approximately fifty 4–5-day-old female An. gambiae mosquitoes via an artificial
membrane attached to a water-jacketed glass feeder maintained at 37˚C. At the end of the feed-
ing experiment, fully blood fed mosquitoes were kept and fed with glucose at 29˚C for 7 days
to allow the development of mature oocysts on the mosquito gut. On day 8, dissected mosquito
guts (Mean number = 40) were stained with 1% mercurochrome and screened for oocysts
using light microscopy. The numbers of oocysts were confirmed by two independent micro-
scope readers, counted and recorded per mosquito.
Serological assays. To study the effect of naturally acquired immunity on human-mos-
quito transmission, plasma from the same blood samples used for parasite detection and mos-
quito feeding assays were screened for P. falciparum sexual stage immunity against Pfs48/45
and Pfs230 antigens. Anti-sporozoite immunity against NANP6 antigen was assessed and used
as a marker of exposure to sporozoites as well as a non-transmission reducing (human-to-
mosquito) immune marker to improve interpretation of Pfs48/45 and Pfs230 anti-gametocyte
immune profiles. Antibody titers were not determined and sera were tested at one dilution per
antigen. The optical density (OD) at this dilution was used as a proxy for antibody density, as
commonly done.
Pfs48/45 and Pfs230 ELISA. Mature P. falciparum NF54 strain gametocytes produced in
an automated static culture system were purified [55] and used to extract Pfs48/45 and Pfs230
native antigens. Briefly, the presence of anti-Pfs48/45 and anti-Pfs230 immunoglobulin G
(IgG) antibodies in participant’s plasma samples were determined by coating 10μg/mL of
anti-Pfs48/45 rat monoclonal antibody 85RF45.3 and anti-Pfs230 rat monoclonal antibody
63F6D7-F(ab). Free sites were blocked with milk (Marvel, Premier International Foods Ltd,
Spalding, Lincs, United Kingdom). Pfs48/45 and Pfs230 antigens from gametocyte extract
(250,000 gametocytes equivalents/well) were captured overnight. Plasma samples at 1:100 dilu-
tion were added to the wells prepared with and without antigen (control wells) for 2 hours
incubation. The plate was then washed and specific bound IgG antibodies were detected by
reaction to Goat-anti Human IgG-Peroxydase (H+L; Pierce). Wells were further washed and
subsequently incubated with tetramethyl benzidine (TMB) substrate. The color reaction was
stopped with 4N H2SO4, and the optical density (OD) was read at 450 nm in an Anthos 2001
Microplate Reader (Labtec BV). All plasma samples were tested in duplicate. Three non-
immune plasma samples randomly selected from Dutch blood bank donor’s plasma samples
were used as negative controls and one positive-control plasma of a Dutch expatriate who had
Sexual stage immunity and transmission of malaria low density infections
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been exposed to malaria for almost 30 years in Sub-Saharan Africa were included per plate.
The cutoff was calculated as the mean OD of negative controls plus three standard deviations.
A sample was considered positive if its OD value density was above the cutoff.
NANP6 ELISA consisted of coating 1μg/mL of NANP6 antigen in flat bottom high binding
microdensity 96 wells plate (NUNCTM Maxisorp, Nalge Nunc International Corp, Life
Techn, The Netherlands). After overnight incubation at 4˚C, coated plates were washed and
free sites blocked with milk as above. Subsequently, the blocking buffer was washed off and
plates incubated at room temperature with 1:100 diluted plasma samples. Plates were then
washed and incubated with rabbit anti-human IgG-Peroxidase (Dako, P-214) before reaction
with the substrate. The rest of the procedure corresponds to that describe for Pfs48/45 and
Pfs230 ELISA. A plasma sample was considered positive if the OD value was greater than three
standard deviations above the mean of the negative control plasma samples [24]. All ELISA
experiments were well standardized and reproducible. Outliers in OD densities were kept in
the data analysis as common natural events due to individual variations upon exposure to
intense malaria transmission and or other co-infections.
Sample size
As described elsewhere [11], we were not able to estimate samples sizes based on experimental
mosquito’s infection rates due to the paucity of age and season-related mosquito feeding data.
Serological sampling for the current study was never presented but part of a previous study
that compared parasite prevalence between age groups. For that study question, that informed
sample size, pre-existing age profiles of parasite rates determined by QT-NASBA in the present
study area [15] were used. An enrollment and follow-up of 50 volunteers < 15 years and 50
volunteers 15 years of age would allow over 85% power to detect a significant difference in
gametocyte prevalence between the two age groups at the two-tailed 5% significance level.
Data analysis using statistical models
All statistical analyses were performed in R version 3.3.1. Gametocyte positive samples in the
Pfs25 mRNA QT-NASBA were considered submicroscopic if negative by microscopy. Median
densities (optical density) of Pfs230 and Pfs48/45 antibodies were categorized by age group (1–
4, 5–14 or 15+ years), season (start-wet, peak-wet or dry) and gametocyte density (sub-micro-
scopic or microscopic) to describe antibody density dynamics. The proportion of seropositive
individuals and infected mosquitoes were categorized by age group (1–4, 5–14, 15–30 and
30+ years) to describe antibody prevalence and mosquito infection dynamics. A Wilcoxon
rank sum test was used to compare the mean oocyst density between samples seronegative ver-
sus seropositive to Pfs48/45 and Pfs230 antigens at different gametocyte densities (Submicro-
scopic, 0.01–16, 17–100,100 gametocytes/μL). A statistical test was considered significant if
p 0.05.
A generalized linear mixed effect model (GLMM) was used to assess the impact of P. falcip-
arum sexual stage immunity on oocyst intensity. The intensity of P. falciparum oocysts per
individual mosquito midgut and per participant was used in this model as a proxy of human-
to-mosquito transmission capability. Because natural malaria infections in endemic areas are
unique to individuals, sophisticated regression analyses that account for confounding factors
are required to isolate the effect of specific immune factors on malaria transmission. The
GLMM grounded in R software AD Model Builder framework accounting for zero inflation,
over-dispersion and repeated measurements was used to estimate the effects of anti-Pfs48/45
and Pfs230 antibodies on oocyst intensity assuming a negative binomial distribution of
oocysts counts in the mosquito population. Only gametocyte positive individuals (i.e. with
Sexual stage immunity and transmission of malaria low density infections
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007034 May 9, 2018 6 / 23
density 0.01 gametocyte/μL by QT-NASBA) were included in the model. Factors influenc-
ing human-to-mosquito transmission including participant’s age, season and microscopy
asexual parasite prevalence were included as covariates in the model in addition to gametocyte
density as key predictor. Given that all mosquitoes were exposed to a constant duration of
blood meal uptake in a repeated measurement scenario, subject’s identity and number of dis-
sected mosquitoes were included as random effect and offset variables respectively to allow for
within-subject correlation and normalization of the variable number of dissected mosquitoes
across individuals. Transmission reducing-effects of model were estimated based on corre-
sponding adjusted regression coefficients. Regression coefficients (β values) that associated
with Pfs48/45 and Pfs230 antibodies were transformed into odd ratios (eβ) and the transmis-
sion-reducing activity of P. falciparum sexual stage immunity on oocyst intensity defined as
TRAoocyst = 1 − eβ.
Modeling the dynamics of sexual-stage immunity and the infectious
reservoir for malaria
A birth cohort of 100 individuals was simulated over a period of 50 years using the EMOD
model configured as in [51] with incidence of new infections matching the seasonal transmis-
sion characteristics of Burkina Faso. Simulated sexual-stage antibody concentrations for
Pfs48/45 and Pfs230 were boosted in response to simulated gametocyte densities each day
before decaying with a 1-month half-life—consistent with the immunoglobulin G half-life [56,
57] and with repeat observations from this and other cohort studies (S1 Fig). Procedures for
antibody half-life estimates are described in S1 Appendix in section 1 and 2. An alternative
approach to estimate antibody half-life that fits a simple equation to time between serological
measurements estimated half-lives of 46.4 days for Pfs230 and 142 days for Pfs48/45 (see S1
Appendix – Section 1). The reason for the disparity in estimates for Pfs48/45 is uncertain but
may be related to antibody boosting by regular antigen re-exposure that is evident in the study
site [11, 58, 59] and not incorporated in the simple antibody decay model. Boosting rates were
fitted for each antigen to match the observed features of antibody density distributions—
median densities and inter-quartile ranges by age, season, and current gametocyte density—
under the structural assumptions that higher gametocyte densities may boost more strongly
and that age-dependent cumulative exposure may impact the magnitude of the boost and the
inter-individual variation within a smoothness constraint (S1 Appendix). An age-matched set
of simulated trajectories was sampled at the 3 time points corresponding to the survey data.
Results
One hundred and twenty-eight study participants with both P. falciparum sexual stage immu-
nity and mosquito’s feeding data were included in the data analysis. On the three occasions of
seasonal sampling time points, 66 of the study participants were visited on three occasions, 31
twice and 31 once resulting in a total of 291 blood samples. NANP6 antibody density and para-
site density by QT-NASBA were obtained from 284 and 285 respectively of the 291 blood
samples.
Pfs48/45, Pfs230 and NANP6 antibody profiles
The overall prevalence of NANP6 antibodies was 78.1% (222/284) and this antibody prevalence
increased significantly with age (Adjusted β (regression coefficient) = 0.838, se = 0.288,
p = 0.0037, Table 1). The density of NANP6 antibodies also increased with age (β = 1.032,
se = 0.29, p< 0.001) and season with the lowest levels recorded at the start (0.4752) of the wet
Sexual stage immunity and transmission of malaria low density infections
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season compared to the peak (0.7165) and dry season (0.8302) (β = -0.387, se = 0.164,
p = 0.018).
Compared to NANP6, a smaller proportion of samples showed reactivity to Pfs48/45
(22.6%) and Pfs230 (33.6%) (Table 1); only 12% (36/291) of the samples reacted to both Pfs230
and Pfs48/45 antigens. Antibody density and seroprevalence were lower for Pfs48/45 com-
pared to Pfs230. Pfs230 antibody prevalence was significantly higher in adults (β = 1.150,
se = 0.445, p = 0.0097, Table 1), and adults also had higher relative antibody densities (β =
0.5289, se = 0.2502, p = 0.0345). In contrast to Pfs48/45 (Fig 2g), the prevalence and density of
Pfs230 antibodies in individuals15 years of age dropped at the peak of the wet season,
although not significantly (Fig 2c).
The prevalence of Pfs48/45 antibody increased with age up to 30 years but declined in older
age (adjusted β = 0.871, se = 0.507, p = 0.086, Table 1), and prevalence was higher (adjusted
β = 0.470, se = 0.3012, p = 0.12) at the peak of the wet season (31%, 30/96) compared either
to the start of the wet season (17%, 18/102) or to the dry season (19%, 18/93). Interestingly,
although not statistically significant, the decline in Pfs48/45 antibody after 30 years of age coin-
cided with a drop in the mean gametocyte density in that population from onset (80.5 gameto-
cytes / μL) to peak transmission (58.7 gametocytes / μL).
Pfs48/45 antibody density also showed an age-related trend (Adjusted β = 0.2581,
se = 0.2629, p = 0.451) and reached a peak during the wet season (Fig 2e and 2g) although not
significantly (β = 0.1064, se = 0.1752, p = 0.544).
Reflecting on the characteristics of the dynamical model for Pfs230 (Fig 2d) and Pfs48/45
(Fig 2h) that are required to reproduce the age and seasonal trends observed in the surveys,
two keys features are apparent. First, a relatively short decay half-life is an important driver of
both the seasonal variation and also the inter-individual variation driven by periodic spikes in
gametocyte density (Fig 3 shows an example trajectory). Second, a combination of chronic
submicroscopic boosting and more efficient boosting with cumulative exposure influences the
increasing densities with age, especially for Pfs230.
Table 1. Pfs48/45 and Pfs230 antibody prevalence and densities from Field data and model simulations.
Antigen Pfs48/45 Pfs230 NANP6
Data Field data %
(No/Total)
Model %
(No/Total)
Field data %
(No/Total)
Model %
(No/Total)
Field data %
(No/Total)
Age group (years)
<5 13.51
(5/37)
14.0
(210/1500)
16.21
(6/37)
17.4
(261/1500)
38.9
(14/36)
5–14 26.80
(26/97)
24.23
(727/3000)
24.74
(24/97)
26.13
(784/3000)
64.13
(59/92)
15–29 27.17
(25/92)
25.46
(1146/4500)
41.30
(38/92)
40.0
(1800/4500)
93.41
(85/91)
30+ 15.38
(10/65)
18.08
(1085/6000)
46.15
(30/65)
48.78
(2927/6000)
98.46
(64/65)
Total 22.68
(66/291)
21.12
(3868/15000)
33.67
(98/291)
38.48
(5772/15000)
78.17
(222/284)
Antibody density
Mean 0.6542 0.6187 0.7673 0.7653
Standard deviation 0.3681 0.3662 0.5018 0.5262
Min 0.202 0.0151 0.052 0.0194
Max 2.851 2.0320 2.4653 2.4926
Gametocyte %
Prevalence (n/N)
66%
(188/285)
69%
(10397/15000)
66%
(188/285)
69%
(10397/15000)
https://doi.org/10.1371/journal.ppat.1007034.t001
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P. falciparum sexual stage immunity associates with concurrent gametocyte
density
We further investigated the impact of concurrent gametocyte carriage, either sub-microscopic
or microscopic, on measured P. falciparum sexual stage antibody densities to better under-
stand antibody acquisition and decay upon parasite exposure.
In Fig 2a, under 5, 5–14 and 15+ years old submicroscopic gametocyte carriers presented
with 0.3515, 0.6597 and 0.8394 median Pfs230 antibody densities respectively, which were
lower though not significantly so, compared to densities in microscopic gametocyte carriers
(0.4597, 0.7808, 1.1183 respectively). Similarly, in Fig 2e, under 5, 5–14 and 15+ years old sub-
microscopic gametocyte carriers presented with 0.4640, 0.525 and 0.594 median Pfs48/45
Fig 2. Dynamics of Pfs230 and Pfs48/45 antibody densities by age, season and gametocyte density. Submic gametocyte = Submicroscopic
gametocyte densities ranging from 0.01–4 gametocytes/ μL blood thus negative by microscopy and positive by QT-NASBA. Mic gametocyte =
gametocyte positive by both microscopy and QT-NASBA. Antibody densities of field study participants were measured in subsamples of n = 37, n = 97
and n = 157 samples in age groups 1–4, 5–14 and15 years of age respectively and shown in panel a for Pfs230 and panel e for Pfs45/45. Antibody
densities of simulated individuals were measured in subsamples of n = 1500, n = 3000 and n = 10500 samples in age groups 1–4, 5–14 and15 years of
age respectively and shown in panel b for Pfs230 and panel f for Pfs48/45. Antibody densities of field study participants were measured in subsamples of
n = 102, n = 96 and n = 93 samples during the start, peak and wet seasons respectively and shown in panel c for Pfs230 and panel g for Pfs45/45.
Antibody densities of simulated individuals were measured in subsamples of n = 5000, n = 5000 and n = 5000 samples during the start, peak and wet
seasons respectively and shown in panel d for Pfs230 and panel h for Pfs48/45. Error bars show horizontal lines from top indicating maximum antibody
density, 75% percentile, median (50% percentile), 25% percentile and minimum antibody density. Dots outside shaded boxes represent outliers in the
distribution of antibody densities within the given subsample.
https://doi.org/10.1371/journal.ppat.1007034.g002
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antibody densities respectively whilst microscopic gametocyte carriers had increased though
not significantly so Pfs48/45 median antibody densities (0.5865, 0.4395 and 0.9115
respectively).
GLMM regression models that included age and parasite status showed that microscopic
gametocyte carriers were more likely to have higher Pfs230 (Adjusted OR = 1.52, se = 0.302,
p = 0.164) and Pfs48/45 antibody densities (Adjusted OR = 1.4, se = 0.3282, p = 0.34) than sub-
microscopic gametocyte carriers, although not statistically significantly so.
Whilst anti-gametocyte immunity has been hypothesized to be short-lived [39, 60] anti-
Pfs230 and anti-Pfs48/45 antibodies were detected in a considerable fraction of individuals
Fig 3. Time series dynamics of Pfs230 (a) and Pfs48/45 (b) antibody response against gametocyte density in a simulated malaria infected
individual from birth up to day 3000.
https://doi.org/10.1371/journal.ppat.1007034.g003
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without concurrent gametocytes, plausibly reflecting recent gametocyte exposure. Under 5,
5–14 and 15+ years old gametocyte-negative individuals presented with 0.2031, 0.7868 and
0.7936 median Pfs230 antibody densities and 0.5662, 0.6332 and 0.6524 median Pfs48/45 anti-
body densities, respectively, which tend to be lower than densities in submicroscopic and
microscopic gametocyte carriers (S2 Fig). There was no association or trend between NANP6
antibodies and concurrent gametocyte density (S3 Fig).
The observed pattern of a small but consistent shift in antibody densities for concurrently
detected gametocytes is an expected consequence of the dynamical model for Pfs230 (Fig 2b)
and Pfs48/45 (Fig 2f). Quantitatively, it depends on the gametocyte density varying on a time-
scale that is similar to the antibody decay time and the degree to which higher gametocyte den-
sities resulting in more efficient boosting.
Impact of sexual stage immunity on oocyst intensity in mosquito feeding
assays
P. falciparum gametocytes were detected in 66% of samples (188/284) by QT-NASBA
(Table 1) whilst 32% (96/291) of the total population was infectious to mosquitoes (i.e. infected
at least one mosquito). P. falciparum oocyst counts as enumerated in mosquito’s midguts fol-
lowed a zero-inflated negative binomial distribution (S1 Appendix – Fig 3). Among the 11,440
dissected mosquitoes, 886 mosquitoes were found to be infected with one or more oocysts
ranging from 1 to 97 oocysts.
Oocyst distribution associates with age, season and gametocyte density
Predictors of oocyst intensity were tested in a GLMM, and the estimated coefficients are
shown in Table 2. The intensity of oocysts significantly decreased with age and was lower in
the dry season as compared to the transmission season. In mosquitoes that fed on blood sam-
ples from individuals 15 years of age, the intensity of oocysts was significantly lower
compared to oocyst intensity of mosquitoes fed on blood samples from individuals 5–14
(p = 0.003) and under-5 years old children (p = 0.047, Table 2). Similarly, season was related to
oocyst with an increased oocyst intensity at the start (p = 0.075) and peak of the wet season
(p< 0.001, Table 2). Carriers of gametocytes (100 gametocytes / μl blood) or microscopic
asexual parasites positively associated with oocyst intensity (p< 0.001 for both covariates,
Table 2).
Oocyst intensity associates with Pfs48/45, Pfs230 but not NANP6
antibodies
By investigating the interactions between oocyst counts and antibody densities, adjusting for
gametocyte density, we were able to estimate the transmission reducing activity (TRA) of spe-
cific antibody densities.
Fig 4 illustrates TRA in relation to Pfs230, Pfs48/45 and NANP6 antibodies at various game-
tocyte densities determined by QT-NASBA. At gametocyte density100 gametocytes/μL,
individuals seropositive to both Pfs230 and Pfs48/45 associated with an order of magnitude
reduced oocyst intensities (11 and 11.3-fold respectively, Fig 4a and 4b) in comparison to sero-
negative individuals (p< 0.001). At gametocyte density of 17–100 gametocytes/μL, samples
seropositive for Pfs230 significantly reduced oocyst intensity compared to samples seronega-
tive for Pfs230 (p = 0.03, Fig 4). The same was not true for samples seropositive for Pfs48/45
(Fig 4). At gametocyte density below 16 gametocytes/μL or at the submicroscopic level, we
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observed no statistically significant impact for Pfs230 or for Pfs48/45 seropositivity on oocyst
intensity (p = 0.937 and p = 0.251 respectively).
The GLMM regression analysis estimated—after adjustment for age, season, gametocyte
density and microscopically detectable asexual parasites—a 55.1% and 70% reduction in oocyst
intensity respectively for Pfs48/45 antibody (p< 0.001, Table 2) and Pfs230 (p< 0.001,
Table 3). No reduction of oocyst intensity associated with NANP6 antibodies was observed
(Fig 4c).
Simulated gametocyte densities generated an overall fraction of 39.9% (5998/15000) infec-
tious individuals with an overall mean mosquito infection rate of 5.6% (850/15000) and oocyst
intensity ranging from 0 to 94 (including non-infectious individuals). Based on the values of
TRA estimated from the GLMM regression analysis, the presence of antibody with specificity
for Pfs48/45 or Pfs230 resulted in reductions of 26%, 37% respectively and for both Pfs48/45
and Pfs230 a reduction of 44% in mosquito infection rates (Fig 5).
Modelling the impact of transmission reducing immunity on the
composition and dynamics of the human infectious reservoir
Our findings of an age and season-dependent prevalence and density of antibodies to Pfs48/45
and Pfs230 and a considerable impact of these antibodies on the likelihood of mosquito infec-
tion indicate that incorporating sexual stage immunity in transmission models may improve
our ability to quantify the contribution of different populations to the infectious reservoir for
malaria.
Table 2. Generalized linear mixed model (GLMM) adjusted effects of Pfs48/45 antibody responses on oocyst intensity.
Factor Individuals No Infected mosquitoes No/Total Oocysts No Adjusted β (se) P-value
Age group (years)
30+ 65 12/2579 13 0.0 (Ref.)
15–30 92 142/3546 1351 0.453 (1.171) 0.698
5–14 97 454/3857 1967 3.258 (1.104) 0.003
<5 37 278/1458 1806 2.234 (1.126) 0.047
Season
Dry 93 120/3532 1388 0.0 (Ref.)
Peak wet 96 350/3692 1849 1.060 (0.286) <0.001
Start wet 102 416/4216 1900 0.434 (0.244) 0.075
Microscopy asexual parasite¥
Absence 157 187/5986 473 0.0 (Ref.)
presence 119 663/4846 4591 1.072 (0.231) <0.001
Gametocytes by QT-NASBA, No/ μL¥
<16 150 98/5738 193 0.0 (Ref.)
16–100 52 176/2053 431 0.475 (0.321) 0.139
100 83 604/3367 4500 1.087 (0.320) <0.001
Pfs48/45 antibody
Absence 225 722/8957 4721 0.0 (Ref.)
Presence 66 164/2483 416 -0.801 (0.239) 0.0004
ref. = reference, β = regression coefficient, se = standard error,
 = GLMM accounting for zero inflated negative binomial distribution, random effects and within-individual correlation for repeated measurements.
¥These groups presented with different sample sizes of participants (n = 277 for Microscopy asexual parasite and n = 285 for Gametocytes by QT-NASBA) and therefore
exhibit smaller sample sizes of dissected mosquitoes.
https://doi.org/10.1371/journal.ppat.1007034.t002
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Fig 4. Distribution of oocyst intensity in the presence and absence of Pfs230 (a), Pfs48/45 (b) or NANP6 (c) antibody at
different gametocyte densities. Antibody densities of samples seronegative for Pfs230, Pfs48/45 and NANP6 ranged 0.202–
0.8784, 0.052–0.8784 and 0.0465–0.293 respectively. Antibody densities of samples seropositive for Pfs230, Pfs48/45 and
NANP6 ranged 0.8784–2.851, 0.8784–2.4653 and 0.293–3.5 respectively. Number of participants with submicroscopic, 0.01–
16, 17–100 and 100 gametocytes/μL were 136, 53, 52 and 83 respectively. Number of mosquitoes fed on submicroscopic,
0.01–16, 17–100 and 100 gametocytes/μL were 3633, 1314, 1306, 2311 for Pfs230 seronegative samples and 1671, 709, 747,
1056 for seropositive samples respectively. For Pfs48/45 seronegative samples, the numbers were 4107, 1500, 1460, 2702 and
Sexual stage immunity and transmission of malaria low density infections
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Fig 6a incorporates the smearing of true simulated gametocyte densities to account for
uncertainty in QT-NASBA derived gametocyte density estimates (S1 Appendix – Fig 5 [61]).
This results in a clear over-dispersion of infected mosquitoes spanning a wider range of mea-
sured gametocyte density (100–104 gametocytes/μL). But another important consequence is
that high gametocyte density measurements will appear to be less infectious in groups with
lower true average density (e.g. older ages), since it is proportionately more likely they result
from lower true densities in the tails of the measurement uncertainty distribution [62].
Fig 6b additionally includes the effect of TRA from both Pfs230 and Pfs48/45; the color of
the bubbles corresponds to the Pfs230 antibody density distribution (as an example) across
individuals. The age- and season-dependence of high antibody densities is reflected in the
changing shape of the infectious reservoir between Fig 6a and 6b. In general, there was 1.14
(11.3%/9.9%), 1.24 (7.6%/6.1%), 1.45 (3.2%/2.2%) and 1.5-fold (0.6/0.4) decrease correspond-
ing to 12.2, 19.3, 31 and 33% reductions in mosquito infection rate in the<5, 5–14, 15–30, and
30+ year old individuals because of TRA impact, providing an improved fit to the study site
data as described elsewhere [11]. There was no seasonal impact of TRA on the proportion of
infected mosquitoes.
1197, 523, 593, 665 for seropositive samples respectively. For NANP6 the numbers were 1216, 464, 451, 1208 for seronegative
samples and 4021, 1559, 1572, 2122 for seropositive samples. Note that significance indicates that samples positive for
Pfs230 antibodies present with higher oocyst intensity.
https://doi.org/10.1371/journal.ppat.1007034.g004
Table 3. Generalized linear mixed model (GLMM) adjusted effects of Pfs230 antibody responses on oocyst intensity.
Factor Individuals No Infected mosquitoes No/Total Oocysts No Adjusted β (se) P-value
Age group (years)
30+ 65 12/2579 13 0.0 (Ref.)
15–30 92 142/3546 1351 0.381 (1.279) 0.7
5–14 97 454/3857 1967 2.106 (1.161) 0.06
<5 37 278/1458 1806 3.196 (1.209) 0.008
Season
Dry 93 120/3532 1388 0.0 (Ref.)
Peak wet 96 350/3692 1849 0.007 (0.233) 0.9
Start wet 102 416/4216 1900 -0.081 (70.206) 0.6
Microscopy asexual parasite
Absence 157 187/5986 473 0.0 (Ref.)
presence 119 663/4846 4591 1.631 (0.232) <0.001
Gametocytes by QT-NASBA, No/ μL
<16 150 98/5738 193 0.0 (Ref.)
16–100 52 176/2053 431 2.048 (0.312) <0.001
100 83 604/3367 4500 2.797 (0.311) <0.001
Pfs230 antibody
Absence 193 694/7633 4710 0.0 (Ref.)
Presence 98 192/3807 427 -1.19 (0.243) <0.001
ref. = reference, β = regression coefficient, se = standard error,
 = GLMM accounting for zero inflated negative binomial distribution, random effects and within-individual correlation for repeated measurements. ¥These groups
presented with different sample sizes of participants (n = 277 for Microscopy asexual parasite and n = 285 for Gametocytes by QT-NASBA) and therefore exhibit smaller
sample sizes of dissected mosquitoes.
https://doi.org/10.1371/journal.ppat.1007034.t003
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Fig 5. Predicted prevalence of infected mosquitoes in individuals seronegative for Pfs230 and Pfs48/45 (control), individuals seropositive for
Pfs230, Pfs48/45 or either antigen. Procedures of simulation of oocyst intensity and inference of oocyst prevalence data per individual are described in
S1 Appendix. Number of observations were 15000 in the control group (all seronegative to either antigen), 5662 (37.7% seropositive) in the group
seropositive to Pfs230, 3098 (20.6% seropositive) in the group seropositive to Pfs48/45 and 1804 (12% seropositive) in the group seropositive to either
antigen.
https://doi.org/10.1371/journal.ppat.1007034.g005
Fig 6. Simulated effect of TRA (Pfs230 TRA alone, Pfs48/45 TRA alone or either) on the association between gametocyte density and mosquito
infection prevalence for different age groups and time points in the transmission season. In panel a, the predicted infectious reservoir accounts for
measurement uncertainty of true gametocyte density in the absence of sexual stage immunity effect, in panel b, the predicted infectious reservoir
accounts for measurement uncertainty of true gametocyte density and for transmission reducing immunity. Simulated mosquito infection rates were
estimated using 1500, 3000, 4500 and 6000 mosquito’s feeding outcomes from age groups 1–4, 5–14 15–29 and30 years of age respectively during
each season.
https://doi.org/10.1371/journal.ppat.1007034.g006
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The shape of the association between oocyst prevalence and oocyst intensity (S1 Appendix
– Fig 4 [62]) was not altered by the presence of antibodies against Pfs230 or Pfs48/45 (Fig 5).
Both oocyst prevalence and oocyst intensity were lower for experiments on samples with
detectable antibodies to these antigens with 70% and 55% as best estimate of the reductions in
oocyst intensity related to the presence of antibodies against Pfs230 and Pfs48/45, respectively
(Fig 5).
Discussion
Using a unique set of longitudinal data on malaria-specific antibody responses and infectivity
of gametocytaemic individuals to mosquitoes, we showed that P. falciparum sexual stage
immunity significantly reduces the transmission of microscopic but not submicroscopic game-
tocyte infections. A notable age-dependent decrease in mosquito infection rate is attributed to
both Pfs48/45 and Pfs230 immunity in a computational model. Our simulations reflect and
further support our field findings that P. falciparum sexual stage immunity associates with
recent exposure to gametocyte density and duration of exposure.
Whilst the presence of antibodies against P. falciparum sexual stage antigens in endemic
populations is well established [24, 39, 49], it is currently unknown how this sexual stage
immunity develops in relation to either microscopic or submicroscopic gametocyte carriage
and how it subsequently impacts the likelihood of mosquitoes becoming infected by these
malaria-infected human hosts. Although there is conflicting evidence on the impact of age and
cumulative malaria exposure on sexual stage immunity [63], sexual stage immunity may influ-
ence the composition and dynamics of the human infectious reservoir. We followed an all-age
cohort of individuals with variable gametocyte exposure over distinct transmission seasons
and directly determined their infectiousness to mosquitoes in relation to the presence or den-
sity of sexual stage antibodies against gametocyte/gamete antigens Pfs48/45 and Pfs230.
Pfs48/45 is a pre-fertilization protein on the surface of gametocytes and gametes that has a
central role in male gamete fertility [45] while Pfs230 antibodies mediate lysis of gametes in a
complement-dependent manner [42]. Both antigens are transmission blocking vaccine candi-
dates that elicit up to 100% functional transmission reducing immunity in animal models [45,
64]. In the present study, antibodies against Pfs48/45 and Pfs230 were more commonly
observed in samples with high concurrent gametocyte densities [39, 65]. We did not directly
assess antibody titer by diluting participant plasma samples but used the optical density in
the ELISA assays as indicator of antibody density, as commonly done [66]. Our simulations
indicate a short half-life of anti-Pfs48/45 and anti-Pfs230 antibodies [39]. Although long-lived
antibody responses to gametocyte antigens have been observed in expatriates who retained
functional antibodies for several years after returning from malaria endemic settings [25],
most of the field evidence supports the hypothesis that gametocyte immune responses are
more short-lived than asexual responses [49, 67]. Our estimates of an antibody half-life of
approximately 1 month for both anti-Pfs48/45 and anti-Pfs230 antibodies must be interpreted
with caution. Although the estimates are in line with that from an independent cohort study
from a similar setting in Burkina Faso (see S1 Fig), an alternative, simpler approach to estimat-
ing antibody half-life that assumes an antibody decay as function of time rather than account-
ing for parasite exposure in this time window estimated a longer half-life of anti-Pfs48/45
antibodies. In addition, our ELISA methodology that utilizes native gametocyte antigen may
be limited in sensitivity and may thus have classified samples with low antibody densities as
antibody negative. Because the functionality of sexual stage antibodies is strongly dependent
on density [39, 68, 69] we nevertheless consider it unlikely that we have missed functionally
relevant antibody densities in the current study. At microscopically detectable gametocyte
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densities, the presence of anti-Pfs48/45 and anti-Pfs230 antibodies had a pronounced effect on
the proportion of mosquitoes that became infected and the oocyst burden in these mosquitoes.
Although antibody densities have been previously associated with TRA in both SMFA [39,
68] and DMFA [69], these studies were all performed in selected high-density gametocyte
carriers. Our study is the first to quantify its impact on the infectious reservoir for malaria by
concurrent use of membrane feeding assays, antibody assessments and sensitive gametocyte
detection. We observed that the presence of antibody with specificity for Pfs48/45, for Pfs230
or for either resulted in a reduction of 26, 37 and 44% in mosquito’s infection rate respectively.
We further found that incorporating sexual stage immunity improved the age-related dynam-
ics of the infectious reservoir in simulations. This could be explained by the age-related
increase in Pfs48/45 and Pfs230 antibody prevalence and densities. These antibody responses
did not explain the comparatively lower mosquito infection rates in the dry season when both
antibody prevalence and mosquito infection rates were lower [11]. Older infections surviving
the long dry season [70] appear to be less infectious to mosquitoes by a mechanism indepen-
dent of TRA [71].
We observed a direct relationship between sexual stage antibody responses and recent /
concurrent exposure to gametocytes [24, 60, 67, 68]. We thus used gametocyte density and
duration of exposure (rather than age as proxy for cumulative exposure), as parameters to the
model acquisition of P. falciparum sexual stage immunity. Our simulations closely replicate
our field observations suggesting that age is unlikely to play an independent role in the dynam-
ics of Pfs48/45 and Pfs230 immunity.
However, given the higher Pfs230 antibody density in adults, we could not fully rule out a
role of age on the acquisition of sexual stage immunity. Indeed, an age-dependent expansion
of B cell memory may be an explanation for the observed patterns, as could be the persistent
exposure to gametocyte antigens due to continued low-density gametocytemia, as observed in
40% of adults in the area [11]. While antibody data from three seasonal sampling points
allowed us to infer many characteristics of antibody boosting and waning dynamics, there
remains significant uncertainty in relation to dependency of antibody acquisition or mainte-
nance in relation to gametocyte density and duration of gametocyte carriage. Future longitudi-
nal studies with more frequent sampling will help refine our understanding in these areas
specifically.
To conclude, the present study provides novel insights into how P. falciparum sexual stage
immunity is acquired in seasonal transmission settings and how it impacts infectivity to mos-
quitoes during natural infections and the human infectious reservoir for malaria. Our finding
that P. falciparum sexual stage immunity has very limited impact on the transmissibility of sub-
microscopic gametocytes may contribute to previous findings on their important role in sus-
taining malaria transmission [11, 32, 72]. The finding that P. falciparum sexual stage immunity
associates with concurrent submicroscopic and microscopic gametocyte density has implica-
tions for the future deployment of transmission blocking vaccines where antibody boosting
densities may be dependent on recent high-density gametocyte exposure. Lastly, we show that
P. falciparum sexual stage immunity significantly reduces the infectious reservoir in an age-
dependent manner, legitimizing its incorporation in mathematical models that may be used
for projecting the infectious reservoir in the context of malaria elimination and for testing
future transmission-blocking interventions in silico.
Supporting information
S1 Fig. Individual level of Pfs230 and Pfs48/45 antibody densities in the present and an
independent cohort study [24] from Burkina Faso and best model fits of antibody profiles
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using estimated antibody half-lives. Plasma samples of the independent cohort study were
collected in June, August and December of the same year (2002) as described elsewhere [24]. A
total of 78 individuals were sampled at least twice (13 were visited 3 times and 65 twice) while
246 were seen once (N = 415 ELISA experiments). Antibody densities were measured using
the same ELISA methodology as described in the present study and have never been published.
Field plasma antibody densities are shown in panel a and c (the present study) and in panel e
and g (independent cohort study). Simulated antibody profiles are shown in panel b and d for
half-life of 28 days (the present study) and in panel f and h for half-lives 26 and 32 days (inde-
pendent cohort study).
(TIF)
S2 Fig. Levels of Pfs230 and Pfs48/45 antibody densities per gametocyte carriage status
and age of study participants.
(TIF)
S3 Fig. NANP6 antibody density by age and concurrent gametocyte density. Antibody den-
sities of study participants were measured in subsamples of n = 37, n = 97 and n = 157 samples
in age groups 1–4, 5–14 and15 years of age respectively. Error bars show horizontal lines
from top indicating maximum antibody density, 75% percentile, median (50% percentile),
25% percentile and minimum antibody density. Dots outside shaded boxes represent outliers
in the distribution of antibody densities within the given subsample.
(TIF)
S1 Appendix. Supplemental methods.
(PDF)
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